“…Salivary gland tumors, which account for approximately 3% of all head and neck cancer, are heterogeneous, rendering the identification of their epidemiological characteristics difficult (8). SDC is a rare, aggressive salivary gland malignancy with limited evidence available to guide standard treatment (9).…”